Top compounds associated with response to MLYCD


Feature Type Standardized
Nominal ANOVA
mRNA UNC0638 CTRPv2 pan-cancer AAC 0.082 0.03
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.079 0.03
mRNA tubastatin A CTRPv2 pan-cancer AAC 0.11 0.03
mRNA Nutlin-3 CTRPv2 pan-cancer AAC 0.077 0.03
mRNA MLN4924 CTRPv2 pan-cancer AAC -0.075 0.03
mRNA pifithrin-alpha CTRPv2 pan-cancer AAC -0.081 0.03
mRNA BRD-K24690302 CTRPv2 pan-cancer AAC 0.08 0.03
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.078 0.03
mRNA BRD-K30748066 CTRPv2 pan-cancer AAC -0.27 0.03
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.076 0.03
Download CSV